437 related articles for article (PubMed ID: 26427800)
21. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes.
Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254
[TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
[TBL] [Abstract][Full Text] [Related]
23. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
Li Q; Liu X; Yan W; Chen Y
Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
[TBL] [Abstract][Full Text] [Related]
25. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
27. PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
Khan I; Gothwal A; Sharma AK; Kesharwani P; Gupta L; Iyer AK; Gupta U
Crit Rev Ther Drug Carrier Syst; 2016; 33(2):159-93. PubMed ID: 27651101
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
29. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
30. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.
Kumar V; Bhatt PC; Rahman M; Kaithwas G; Choudhry H; Al-Abbasi FA; Anwar F; Verma A
Int J Nanomedicine; 2017; 12():6747-6758. PubMed ID: 28932118
[TBL] [Abstract][Full Text] [Related]
31. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells.
Verderio P; Pandolfi L; Mazzucchelli S; Marinozzi MR; Vanna R; Gramatica F; Corsi F; Colombo M; Morasso C; Prosperi D
Mol Pharm; 2014 Aug; 11(8):2864-75. PubMed ID: 24945469
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.
Shi W; Yuan Y; Chu M; Zhao S; Song Q; Mu X; Xu S; Zhang Z; Yang K
J Biomater Appl; 2016 Mar; 30(8):1127-41. PubMed ID: 26608458
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.
Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L
Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867
[TBL] [Abstract][Full Text] [Related]
36. In vitro targeted imaging and delivery of camptothecin using cetuximab-conjugated multifunctional PLGA-ZnS nanoparticles.
Deepagan VG; Sarmento B; Menon D; Nascimento A; Jayasree A; Sreeranganathan M; Koyakutty M; Nair SV; Rangasamy J
Nanomedicine (Lond); 2012 Apr; 7(4):507-19. PubMed ID: 22471719
[TBL] [Abstract][Full Text] [Related]
37. A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells.
Bai MY; Liu SZ
Colloids Surf B Biointerfaces; 2014 May; 117():346-53. PubMed ID: 24681046
[TBL] [Abstract][Full Text] [Related]
38. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway.
Sa P; Singh P; Panda S; Swain RK; Dash R; Sahoo SK
Transl Res; 2024 Jun; 268():63-78. PubMed ID: 38499286
[TBL] [Abstract][Full Text] [Related]
39. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
